Moderna Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Moderna, Inc. (MRNA) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents1.938.609.906.854.611.101.52
Short-Term Investments5.105.706.703.881.980.000.00
Cash & Short-Term Investments7.038.609.9010.734.611.101.52
Accounts Receivable0.590.891.393.181.390.010.03
Inventory0.120.200.951.440.050.000.00
Other Current Assets0.170.230.130.030.010.000.00
Total Current Assets8.1010.3313.4316.076.301.131.56
Non-Current Assets
Property, Plant & Equipment (Net)2.962.662.141.380.390.290.21
Long-Term Investments2.514.748.366.840.640.000.00
Goodwill0.050.050.000.000.000.000.00
Intangible Assets0.040.040.000.000.000.000.00
Other Non-Current Assets0.490.770.990.050.010.010.01
Total Non-Current Assets6.048.1012.438.601.040.460.40
Total Assets14.1418.4325.8624.677.341.591.96
Current Liabilities
Accounts Payable0.412.322.640.300.490.070.09
Short-Term Debt0.070.000.000.000.000.000.00
Accrued Liabilities0.901.071.831.350.470.000.00
Deferred Revenue0.150.572.046.253.870.000.00
Other Current Liabilities0.710.130.250.010.030.010.00
Total Current Liabilities2.213.024.929.134.390.140.22
Non-Current Liabilities
Long-Term Debt0.711.221.000.710.210.130.03
Other Non-Current Liabilities0.270.260.140.080.000.000.00
Total Non-Current Liabilities1.041.561.811.400.390.270.21
Total Liabilities3.244.576.7410.524.780.410.43
Stockholders' Equity
Retained Earnings10.0513.4817.959.96-2.24-1.49-1.01
Accumulated Other Comprehensive Income-0.01-0.12-0.37-0.020.000.000.00
Additional Paid-in Capital0.870.371.174.214.802.672.54
Shares Outstanding0.390.380.390.400.000.000.00
Total Stockholders' Equity10.9013.8519.1214.152.561.171.53
Total Liabilities & Equity14.1418.4325.8624.677.341.591.96